Fexapotide (NX-1207 free acid) selectively induces apoptosis to effectively reduce prostate volume at the cellular level and is applicable in the research of lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) [1][2][3].
Molecular Weight:
2055.49
CAS Number:
[492447-54-8]
Formula:
C90H163N27O25S
Target:
Apoptosis
T76275
* VAT and and shipping costs not included. Errors and price changes excepted